Imunon, Inc. (IMNN) Return on equity 2018–2023
Imunon, Inc. (IMNN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-66.5%FY2023 · since FY2018: -44.5% → -66.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -66.5% | -2.2 pp |
| FY2022 | -64.3% | +47.3 pp |
| FY2021 | -111.6% | +36.0 pp |
| FY2020 | -147.6% | -66.8 pp |
| FY2019 | -80.8% | -36.3 pp |
| FY2018 | -44.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice